Fausto Berti holds the position of SVP Late Stage Development.
Fausto came to Alvotech with 15 years of experience in Clinical Research. He has been involved in the clinical development of biosimilars since 2009, working on different successful programs. Prior to joining Alvotech, Fausto was a key contributor to the formation of the clinical team at Mylan Biologics, where he was directly involved in all clinical activities for the first wave of biosimilars products.
Prior to working on biosimilars, Fausto had different roles in the management of clinical studies across several therapeutic areas, mainly Oncology, CNS and Autoimmune diseases, both in International Contract Research Organization (PPD and INC Research) and biotech companies (Actelion and BiogenIdec).
Fausto holds a Pharm.D. degree and Ph.D. in Pharmacology/Toxicology, both gained at the University of Bologna (Italy).